Thermal Burn Clinical Trial
Official title:
An Adaptive, Randomized, Controlled Trial Evaluating the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag® Used as Standard of Care in the Treatment of Adult and Pediatric Partial Thickness Burns.
A total of 68 adult and pediatric patients who suffer from at least one discrete partial thickness thermal burn wound (Grade II) will be recruited. Subjects will be randomized (1:1) to either PermeaDerm® or Mepilex Ag®. Evaluations will occur at 7, 14 and 21 days with long term follow-up at 6 and 12 months.
A total of 68 adult and pediatric patients who suffer from at least one discrete partial thickness thermal burn wound (Grade II) will be recruited from the clinical practices of the site Principal Investigators. Participants and/or the Legally Authorized Representative (LAR) as appropriate will be fully informed regarding the conduct of the clinical trial including all potential risks and benefits. All Participants must be consented, randomized (1:1) and treated within 72 hours of injury. It is permissible for a Study Participant to be enrolled if they have more than one burn wound. If more than one partial thickness burn is treated, the Investigator must indicate prior to randomization which wound is to be considered for primary analysis. This wound will be called the Primary Wound and is to be evaluated by a Blinded Assessor. Additional partial thickness wounds must be treated with the same product to which the Study Participant was randomized and will be included in secondary analysis. These wounds are to be described as Secondary Wounds and are to be evaluated by the Unblinded Assessor. Evaluations will occur at 7, 14 and 21 days with long term follow-up at 6 and 12 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04368117 -
STAT: Standard Therapy Plus Active Therapy
|
N/A | |
| Recruiting |
NCT06223269 -
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
|
Phase 3 | |
| Completed |
NCT05167461 -
AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)
|
||
| Terminated |
NCT03148977 -
Evaluating MMPs in Burns
|
||
| Completed |
NCT02362386 -
Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
|
N/A | |
| Completed |
NCT04073030 -
Burn Injury In a Child Due to Cyanoacrylate-Based Nail Glue- Case Report and Literature Review
|
||
| Recruiting |
NCT04138394 -
VItamin C in Thermal injuRY: The VICToRY Trial
|
Phase 3 | |
| Withdrawn |
NCT03248154 -
Biofilm Infection in Adults and Children Burn Injury
|
N/A | |
| Completed |
NCT04500314 -
Efficacy of Whole-body Vibration on Balance Control, Postural Stability and Mobility After Thermal Burn Injuries.
|
N/A | |
| Withdrawn |
NCT04684121 -
Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
|
Phase 2 | |
| Terminated |
NCT03077087 -
Single-Stage Integra Reconstruction in Burns
|
N/A | |
| Suspended |
NCT03435172 -
Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds
|
N/A | |
| Available |
NCT04040660 -
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
|